Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
Company Details
- Employees
- 4
- Address
- Boston, Massachusetts 02215, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://oncopep.com
- Keywords
- Oncology, T Cell, Immunotherapeutics, Biotechnolgy.
- HQ
- Boston, Massachusetts
Oncopep, Inc. Questions
Oncopep, Inc.'s website is http://oncopep.com
Oncopep, Inc.'s LinkedIn profile is https://www.linkedin.com/company/oncopep-inc.
Oncopep, Inc. has
4 employees.
View email and phone details for 4
employees at Oncopep, Inc..
Oncopep, Inc.'s industry is
Biotechnology Research
Oncopep, Inc.'s top competitors are
Curie.bio,
Zinio,
Onconova Therapeutics,
Visgenx, Inc,
Global Bioaccess Fund,
Cobro Ventures,
Oncopeptides Ab (Publ),
Kymera Therapeutics,
Visgenx,
Rhythm Pharmaceuticals Inc..
Oncopep, Inc.'s categories are Biotechnology Research
